1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Stille AB (STIL) - Medical Equipment - Deals and Alliances Profile

Summary

Stille AB (Stille) is a medical device company. It develops and manufactures surgical instruments, specialty operating tables, headlights and retractor systems. The company offers instruments and specialty tables for cardiovascular and thoracic surgery, neuro surgery, general surgery, orthopedic surgery, plastic surgery, urology and gynecology areas. It manufactures more than 1,200 specialty surgical instruments, including scissors, tweezers, forceps, artery forceps, needle holders, vascular clamps, retractors, rongeurs, chisels, rasps and microsurgical instruments, among others. The company sells its fluoroscopy-enabled operating tables under the brand name, imagiQ2. Stille also undertakes the resale of related products manufactured by other companies. The company operates in Nordic countries, the US, Europe and Asia. Stille is headquartered in Solan, Sweden.

Stille AB (STIL) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Stille AB (STIL) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Stille AB, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Stille AB, Medical Equipment Deals By Type, 2010 to YTD 2016 6
Stille AB, Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Stille AB, Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Stille AB, Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Stille AB, Medical Equipment, Deal Details 10
Partnerships 10
Stille Enters Into Distribution Agreement With Ziehm Imaging 10
Schaerer Medical Enters Into Co-Marketing Agreement With Stille For imagiQ 11
United Drug Enters Into Distribution Agreement With Stille 12
Lawton Enters Into Distribution Agreement With Stille 13
Acquisition 14
ADDvise Lab Solutions Completes Acquisition Of Stille-Sonesta From Stille For US$3 Million 14
Stille AB - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations and Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Stille AB, Medical Equipment, Key Facts, 2015 1
Stille AB, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Stille AB, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Stille AB, Medical Equipment Deals By Type, 2010 to YTD 2016 6
Stille AB, Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Stille AB, Deals By Market, 2010 to YTD 2016 8
Stille AB, Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Stille Enters Into Distribution Agreement With Ziehm Imaging 10
Schaerer Medical Enters Into Co-Marketing Agreement With Stille For imagiQ 11
United Drug Enters Into Distribution Agreement With Stille 12
Lawton Enters Into Distribution Agreement With Stille 13
ADDvise Lab Solutions Completes Acquisition Of Stille-Sonesta From Stille For US$3 Million 14
Stille AB, Key Competitors 15
Stille AB, Key Employees 16
Stille AB, Subsidiaries 17

List of Figures
Stille AB, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Stille AB, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Stille AB, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Stille AB, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Stille AB, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Stille AB, Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Stille AB, Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Stille AB, Medical Equipment, Deals by Market, 2010 to YTD 2016 8

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Ophthalmology Drug Development Pipeline Review, 2016

Ophthalmology Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Ophthalmology Drug Development Pipeline Review, 2016 Summary Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, ...

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N-Formyl ...

Head And Neck Cancer - Pipeline Review, H2 2016

Head And Neck Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

Head And Neck Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an ...

Scar - Pipeline Review, H2 2016

August 2016 $ 2000

Glaucoma - Pipeline Review, H2 2016

September 2016 $ 2000

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.